Common familial risk factors for schizophrenia and diabetes mellitus

Objective: The co-occurrence of type 2 diabetes and psychosis is an important form of medical comorbidity within individuals, but no large-scale study has evaluated comorbidity within families. The aim of this study was to determine whether there is evidence for familial comorbidity between type 2 diabetes and psychosis. Method: Data were analysed from an observational study of a nationally representative sample of 1642 people with psychosis who were in contact with psychiatric services at the time of survey (The 2010 Australian National Survey of Psychosis). Participants were aged 18–64 years and met World Health Organization’s International Classification of Diseases, 10th Revision diagnostic criteria for a psychotic disorder (857 with schizophrenia, 319 with bipolar disorder with psychotic features, 293 with schizoaffective disorder, 81 with depressive psychosis and 92 with delusional disorder or other non-organic psychoses). Logistic regression was used to estimate the association between a family history of diabetes and a family history of schizophrenia. Results: A positive family history of diabetes was associated with a positive family history of schizophrenia in those with a psychotic disorder (odds ratio = 1.35, p = 0.01, adjusted for age and gender). The association was different in those with an affective versus non-affective psychosis (odds ratio = 0.613, p = 0.019, adjusted for age and gender) and was significant only in those with a non-affective psychosis, specifically schizophrenia (odds ratio = 1.58, p = 0.005, adjusted for age and sex). Adjustment for demographic factors in those with schizophrenia slightly strengthened the association (odds ratio = 1.74, p = 0.001, adjusted for age, gender, diagnosis, ethnicity, education, employment, income and marital status). Conclusion: Elevated risk for type 2 diabetes in people with schizophrenia is not simply a consequence of antipsychotic medication; type 2 diabetes and schizophrenia share familial risk factors.

[1]  Igor Zwir,et al.  Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. , 2015, The American journal of psychiatry.

[2]  A. Mackinnon,et al.  Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis , 2014, World psychiatry : official journal of the World Psychiatric Association.

[3]  A. Mackinnon,et al.  Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis , 2014, Psychological Medicine.

[4]  V. Maksimov,et al.  Family History of Autoimmune Thyroid Disease , 2013 .

[5]  D. Malaspina.  Looking schizophrenia in the eye. , 2013, The American journal of psychiatry.

[6]  P. Lichtenstein,et al.  Critical need for family-based, quasi-experimental designs in integrating genetic and social science research. , 2013, American journal of public health.

[7]  A. Lupo,et al.  A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients , 2013, BMC Medical Genomics.

[8]  Youping Deng,et al.  Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis , 2013, BMC Medical Genomics.

[9]  A. Mackinnon,et al.  People living with psychotic illness in 2010: The second Australian national survey of psychosis , 2012, The Australian and New Zealand journal of psychiatry.

[10]  D. Cohen,et al.  Endogenic and Iatrogenic Diabetes Mellitus in Drug-naïve Schizophrenia: The Role of Olanzapine and its Place in the Psychopharmacological Treatment Algorithm , 2011, Neuropsychopharmacology.

[11]  A. Shuldiner,et al.  Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes , 2010, Schizophrenia Research.

[12]  C. Correll,et al.  Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients , 2010, Neuropsychopharmacology.

[13]  R. V. Van Lieshout,et al.  Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms. , 2008, Journal of psychiatry & neuroscience : JPN.

[14]  B. Kirkpatrick,et al.  Glucose abnormalities in the siblings of people with schizophrenia , 2008, Schizophrenia Research.

[15]  M. Woodward,et al.  First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. , 2008, The British journal of psychiatry : the journal of mental science.

[16]  B. Kirkpatrick,et al.  Parental history of Type 2 diabetes in patients with nonaffective psychosis , 2008, Schizophrenia Research.

[17]  G. Rossi,et al.  Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). , 2008, Diabetes Care.

[18]  J. Thakore,et al.  Impaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[19]  P. Masand,et al.  Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies. , 2006, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[20]  F. Bellivier.  Schizophrenia, antipsychotics and diabetes: Genetic aspects , 2005, European Psychiatry.

[21]  F. Rouillon,et al.  Schizophrenia and diabetes: Epidemiological data , 2005, European Psychiatry.

[22]  M. O’Donovan,et al.  Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? , 2005, Journal of psychopharmacology.

[23]  G. Valuri,et al.  The diagnostic interview for psychoses (DIP): development, reliability and applications , 2005, Psychological Medicine.

[24]  Robert Atkins,et al.  The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. , 2002, Diabetes care.

[25]  Peter B. Jones,et al.  Family history of autoimmune diseases in psychosis , 1996, Schizophrenia Research.

[26]  D. Schnur,et al.  FAMILY HISTORY OF TYPE 2 DIABETES IN SCHIZOPHRENIC PATIENTS , 1989, The Lancet.

[27]  R. Williams,et al.  Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. , 1988, American journal of human genetics.

[28]  P. Taverna,et al.  [Schizophrenia and diabetes]. , 1960, Rivista di patologia nervosa e mentale.